Lowering immune suppression drugs post-transplant may cut cancer risk.
McCann
Jean
J
D004305:Dose-Response Relationship, Drug; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D009369:Neoplasms / Q000276:immunology* / Q000517:prevention & control*; D016377:Organ Transplantation; D014019:Tissue Donors
D007166:Immunosuppressive Agents